http://www.clinicaltrials.gov/ct/show/NCT00225069

- no tienen ni puetera idea de porque se producen los debastadores efectos secundarios de la operacion y siguen con sus macabros experimentos, reclutando pacientes para que se operen de sudor facial por ETS y estudiar los efectos secundarios y estudiar las diferencias entre cortando el T2 o el T2-T3
- es increible que sigan experimentando con peronas humanas, y encima el estudio esta vigente hasta el 2008
- excluyen de este experimento a personas que hayan tenido en el pasado problemas de bradicardias o arritmias porque es eso lo que quieren estudiar, el dao que hace la operacion ETS en el funcionamiento de nuestros pulmones y nuestro corazon.


//////////////////
Clinical Trials for FB ~ Denmark
--------------------------------------------------------------------------------
 Link

Thoracoscopic Sympathectomy for Blushing

This study is currently recruiting patients.
Verified by Odense University Hospital September 2005

Sponsors and Collaborators: Odense University Hospital 
Aarhus University Hospital 
Information provided by: Odense University Hospital 
ClinicalTrials.gov Identifier: NCT00225069 


Purpose 

To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy. 
Condition Intervention Phase 
Facial Blushing
Procedure: T2 sympathectomy or T2-T3 sympathectomy
Phase IV


MedlinePlus consumer health information 


Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study 

Official Title: Thoracoscopic Sympathectomy for Blushing. A Prospective Randomised Trial.

Further Study Details: 
Primary Outcomes: Effect of operation. Side effects: compensatory and gustatory sweating.
Expected Total Enrollment: 200 
Study start: September 2005; Expected completion: March 2008
Last follow-up: March 2008; Data entry closure: March 2008 

Eligibility 

Ages Eligible for Study: 18 Years - 70 Years, Genders Eligible for Study: Both 
Criteria
Inclusion Criteria:

Isolated disabling facial blushing 
Over 18 years of age 
Willing to be randomized 
Exclusion Criteria:

Primary hyperhidrosis in palms or axillae 
Previous lung surgery 
Bradycardia 
Arrythmias 
Pregnancy 
Location and Contact Information 

Please refer to this study by ClinicalTrials.gov identifier NCT00225069 

Peter B Licht, MD PhD +45 65413385 licht@dadlnet.dk


Denmark
Dept Cardiothorcic Surgery, Odense University Hospital, Odense, 5000, Denmark; Recruiting 
Peter B Licht, MD PhD +45 6541 3385 licht@dadlnet.dk 
Peter B Licht, MD PhD, Principal Investigator


Dept Cardiothoracic Surgery, Skejby Sygehus, Aarhus University Hospital, Aarhus, 8200, Denmark; Not yet recruiting 
Hans K Pilegaard, MD +45 89495426 pilegaard@dadlnet.dk 
Hans K Pilegaard, MD, Principal Investigator



Study chairs or principal investigators 

Peter B Licht, MD PhD, Principal Investigator, Odense University Hospital, Denmark 
Hans K Pilegaard, MD, Study Chair, Skejby Sygehus, Aarhus University Hospital 
More Information 

Study ID Numbers: TOPSY1-2005
Last Updated: December 8, 2005
Record first received: September 21, 2005
ClinicalTrials.gov Identifier: NCT00225069
Health Authority: Denmark: National Board of Health
ClinicalTrials.gov processed this record on 2006-01-04 